000145627 001__ 145627
000145627 005__ 20231212102202.0
000145627 0247_ $$2doi$$a10.1109/AIVR46125.2019.00054
000145627 037__ $$aDZNE-2020-00957
000145627 041__ $$aEnglish
000145627 1001_ $$0P:(DE-2719)2812503$$aStreck, Adam$$b0$$eFirst author$$udzne
000145627 1112_ $$a2019 IEEE International Conference on Artificial Intelligence and Virtual Reality (AIVR)$$cSan Diego, CA$$d2019-12-09 - 2019-12-11$$wUSA
000145627 245__ $$aNeomento sad-vr treatment for social anxiety
000145627 260__ $$c2019
000145627 3367_ $$033$$2EndNote$$aConference Paper
000145627 3367_ $$2DataCite$$aOther
000145627 3367_ $$2BibTeX$$aINPROCEEDINGS
000145627 3367_ $$2DRIVER$$aconferenceObject
000145627 3367_ $$2ORCID$$aLECTURE_SPEECH
000145627 3367_ $$0PUB:(DE-HGF)6$$2PUB:(DE-HGF)$$aConference Presentation$$bconf$$mconf$$s1702372880_1342$$xOther
000145627 520__ $$aWe present the neomento project, a solution for virtual reality (VR) exposure therapy (VRET). In our work we have created specific rendering methods and virtual environments (VEs); designed and published a novel form of behavioural control for virtual agents (VA); included biophysiological measurements directly into the experience; and created an asymmetric gameplay system to assure the correct progress of a therapy session. This is a reprint of ©2019 IEEE, with the title, acknowledgement, references, the Fig. 1, and phrasing updated.
000145627 536__ $$0G:(DE-HGF)POF3-344$$a344 - Clinical and Health Care Research (POF3-344)$$cPOF3-344$$fPOF III$$x0
000145627 588__ $$aDataset connected to CrossRef Conference
000145627 7001_ $$0P:(DE-2719)2812507$$aStepnicka, Philipp$$b1$$udzne
000145627 7001_ $$0P:(DE-2719)2812504$$aKlaubert, Jens$$b2$$udzne
000145627 7001_ $$0P:(DE-2719)2810583$$aWolbers, Thomas$$b3$$eLast author$$udzne
000145627 773__ $$a10.1109/AIVR46125.2019.00054
000145627 8564_ $$uhttps://ieeexplore.ieee.org/stamp/stamp.jsp?arnumber=8942236
000145627 8564_ $$uhttps://pub.dzne.de/record/145627/files/DZNE-2020-00957_Restricted.pdf
000145627 8564_ $$uhttps://pub.dzne.de/record/145627/files/DZNE-2020-00957_Restricted.pdf?subformat=pdfa$$xpdfa
000145627 909CO $$ooai:pub.dzne.de:145627$$pVDB
000145627 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812503$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000145627 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812507$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000145627 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812504$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b2$$kDZNE
000145627 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810583$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000145627 9131_ $$0G:(DE-HGF)POF3-344$$1G:(DE-HGF)POF3-340$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lErkrankungen des Nervensystems$$vClinical and Health Care Research$$x0
000145627 9141_ $$y2019
000145627 9201_ $$0I:(DE-2719)1810004$$kAG Schmitz$$lNetwork Dysfunction$$x0
000145627 9201_ $$0I:(DE-2719)1310002$$kAG Wolbers$$lAging, Cognition and Technology$$x1
000145627 980__ $$aconf
000145627 980__ $$aVDB
000145627 980__ $$aI:(DE-2719)1810004
000145627 980__ $$aI:(DE-2719)1310002
000145627 980__ $$aUNRESTRICTED